Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The trans-ancestral genomic architecture of glycemic traits

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Genetic analyses identify widespread sex-differential participation bias

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Large-scale association analyses identify host factors influencing human gut microbiome composition

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Differences in insulin sensitivity in the partial remission phase of childhood type 1 diabetes; a longitudinal cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cathepsin C Regulates Cytokine-Induced Apoptosis in β-Cell Model Systems

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Type 1 Diabetes Genetics Consortium
View graph of relations

We report the largest and most diverse genetic study of type 1 diabetes (T1D) to date (61,427 participants), yielding 78 genome-wide-significant (P < 5 × 10-8) regions, including 36 that are new. We define credible sets of T1D-associated variants and show that they are enriched in immune-cell accessible chromatin, particularly CD4+ effector T cells. Using chromatin-accessibility profiling of CD4+ T cells from 115 individuals, we map chromatin-accessibility quantitative trait loci and identify five regions where T1D risk variants co-localize with chromatin-accessibility quantitative trait loci. We highlight rs72928038 in BACH2 as a candidate causal T1D variant leading to decreased enhancer accessibility and BACH2 expression in T cells. Finally, we prioritize potential drug targets by integrating genetic evidence, functional genomic maps and immune protein-protein interactions, identifying 12 genes implicated in T1D that have been targeted in clinical trials for autoimmune diseases. These findings provide an expanded genomic landscape for T1D.

Original languageEnglish
JournalNature Genetics
Volume53
Issue number7
Pages (from-to)962-971
Number of pages10
ISSN1061-4036
DOIs
Publication statusPublished - Jul 2021

Bibliographical note

© 2021. Crown.

    Research areas

  • Alleles, Autoimmunity/genetics, CD4-Positive T-Lymphocytes/immunology, Chromosome Mapping, Diabetes Mellitus, Type 1/drug therapy, Drug Discovery, Gene Expression, Genetic Predisposition to Disease, Genetic Variation, Genomics/methods, Humans, Molecular Targeted Therapy, Protein Interaction Mapping

ID: 69076647